Kristin Wynholds - Dec 18, 2023 Form 4 Insider Report for Better Therapeutics, Inc. (BTTX)

Role
Chief Product Officer
Signature
/s/ Leslie Miller, Attorney-in-fact
Stock symbol
BTTX
Transactions as of
Dec 18, 2023
Transactions value $
$0
Form type
4
Date filed
12/20/2023, 05:23 PM
Previous filing
Apr 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTTX Common Stock Award $0 +25.4K +12.66% $0.00 226K Dec 18, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person was awarded 25,362 Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock. The RSU shall vest on June 1, 2024.